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A B S T R A C T
Understanding the cellular and molecular mechanisms that determine whether inflammation resolves or progresses to scarring and tissue destruction should lead to the development of effective therapeutic strategies for inflammatory diseases. Apoptosis of neutrophil granulocytes is an important determinant of the resolution of inflammation, providing a mechanism for downregulation of function and triggering clearance by macrophages without inducing a proinflammatory response. However, if the rate of cell death by apoptosis is such that the macrophage clearance capacity is exceeded, apoptotic cells may progress to secondary necrosis, resulting in the release of harmful cellular contents and in damage to the surrounding tissue.
There are many possible ways in which the rate and capacity of the macrophage-mediated clearance of apoptotic cells may be enhanced or suppressed. Ligation of human macrophage surface CD44 by bivalent monoclonal antibodies rapidly and profoundly augments the capacity of macrophages to phagocytose apoptotic neutrophils in vitro. The molecular mechanism behind this effect and its potential significance in vivo is a current focus of research.
NEUTROPHIL APOPTOSIS PROMOTES THE RESOLUTION OF INFLAMMATION
During inflammation, neutrophils are stimulated to release granule enzymes, oxidants and inflammatory mediators by bacterial products, cytokines and adhesion to matrix components and neighbouring cells [1] . Uncontrolled or inappropriate release of these histotoxic substances may result in damage to host tissues and prolong the inflammatory response. Indeed, neutrophils have been implicated in the pathogenesis of a variety of serious inflammatory diseases, such as fibrosing alveolitis, adult respiratory distress syndrome, rheumatoid arthritis and ulcerative colitis [2] . Neutrophil apoptosis results in the loss of expression of adhesion molecules [3] and greatly reduced responsiveness to external stimuli [4] , so that these cells become functionally isolated from their environment. In contrast with necrosis, apoptosis is associated with preservation of plasma membrane integrity, so that release of harmful neutrophil contents is limited, and the inert neutrophils are phagocytosed by local macrophages. Furthermore, phagocytosis of apoptotic granulocytes by human macrophages in vitro does not stimulate the release of macrophage-derived proinflammatory mediators (in contrast with ingestion of particles opsonized with immunoglobulin) [5] [6] [7] . In this way, by down-regulating neutrophil functions and triggering ' silent ' clearance by phagocytes, apoptosis provides a mechanism for the safe disposal of potentially destructive inflammatory cells. Evidence for a role for leucocyte apoptosis in the resolution of inflammation is supported by the observation that apoptotic granulocytes can be identified within phagocytic vacuoles in macrophages from inflamed joints [8] and the airways of asthmatic patients [9] .
RECOGNITION OF APOPTOTIC CELLS
Clearly, macrophages must be able to recognize changes on the surface of the apoptotic cell that distinguish it from a healthy viable cell. Multiple macrophage surface receptors have been implicated in the recognition and clearance of apoptotic cells [10] [11] [12] . Similarly, in the nematode Caenorhabditis elegans, at least six different genes have been discovered that seem to be required for effective removal of dying cells by phagocytes [13] . The reasons for this redundancy are unclear, but a number of the implicated molecules may be revealed to be indirect regulators of apoptotic cell phagocytosis, rather than true apoptotic cell receptors [14] . During the development of C. elegans, the generation of 959 somatic nuclei is accompanied by the death of 131 cells, and a number of mutations that affect the processes of cell death and the engulfment of dead cells have been identified. Mutations in one of any six genes, ced-1, -2, -5, -6, -7 or -10, prevents some cell corpses from being engulfed, although in all of these mutants most cells were engulfed normally. In contrast, a major defect in engulfment can be found in double mutants in which one mutation is in ced-2, -5 or -10, and the other mutation is in ced-1, -6 or -7 [13] . This observation suggested that the two sets of genes act in parallel processes that are partially redundant. We now know that the proteins encoded by ced-2, ced-5 and ced-10 are similar to human CrkII, Crkbinding protein DOCK180 and Rac respectively, and that these molecules comprise a pathway that controls The genes that are involved in the engulfment of cell corpses during the development of the nematode C. elegans have been divided into two functionally redundant groups (ced-1/ced-6/ced-7 and ced-2/ced-5/ced-10 ). These have been cloned and sequenced, providing evidence for a role for similar molecules in the phagocytosis of apoptotic cells in higher animals.
the organization of the actin cytoskeleton and the extension of cell processes [15] . Mammalian homologues of ced-1, ced-6 and ced-7 have also been identified ( Figure  1 ). Thus the characterization of C. elegans genes that are involved in the phagocytic clearance of cellular corpses in the nematode has elucidated potential roles for a number of key elements of cytoskeletal regulation and signal transduction.
REGULATION OF THE PHAGOCYTOSIS OF APOPTOTIC CELLS
If the rate of cell death by apoptosis is such that the clearance capacity of macrophages is exceeded, apoptotic cells may become necrotic, resulting in the release of harmful cellular contents and damage to the surrounding tissue ( Figure 2 ). In support of this suggestion, treatment of mice with anti-Fas antibody triggered a massive wave of apoptosis in the liver, and the animals developed extensive hepatic necrosis and died [16] . Similarly, induction of apoptosis in the rat lung led to pulmonary fibrosis [17] . We propose that in these situations the hepatic and pulmonary macrophages respectively were unable to clear the load of apoptotic cells with which they were faced. Similar situations could arise if neutrophil apoptosis were to be induced deliberately as part of a therapeutic strategy for inflammatory diseases. Such potential future approaches may therefore have to include a way of concurrently augmenting the clearance efficiency of local macrophages.
Macrophage phagocytic capacity in vitro may be influenced by soluble mediators such as cytokines [18] and prostaglandins [19] , or by glucocorticoid hormones [14, 20] . In addition, the interaction of surface adhesion molecules with neighbouring cells and components of the extracellular matrix may profoundly influence many aspects of cellular behaviour, including phagocytosis [21] . CD44 is a surface receptor that has been implicated in cell adhesion to a variety of matrix components, including fibronectin, and may be associated with cytoskeletal proteins and intracellular signalling pathways [22] . CD44 was therefore an attractive target for our further investigation of how the phagocytosis of apoptotic cells by macrophages may be regulated.
STRUCTURE AND FUNCTION OF CD44
The CD44 gene in humans consists of 50-60 kb located on the short arm of chromosome 11. Some of the 20 or more exons are constitutively transcribed, but a sequence of at least 10 exons (exons 6a-14) undergoes variable splicing, giving rise to an additional peptide sequence between amino acids 202 and 203 in the membraneproximal domain of the CD44 protein [23, 24] (Figure 3 ). CD44 comprises a large extracellular ligand-binding domain, an alternatively spliced membrane-proximal domain containing sites for linkage of large sugars, a highly conserved transmembrane sequence, and a short cytoplasmic tail containing phosphorylation sites.
In practice, only relatively few variant isoforms of CD44 (CD44v isoforms) containing certain combinations of variably spliced CD44 exons have been found to be expressed in human cells. The most prevalent form of CD44, termed CD44S (' standard ') or CD44H (' haematopoietic '), contains no additionally spliced exon products. CD44S is a single-chain type I transmembrane protein containing 341 amino acids, with a predicted molecular mass of 40 kDa. However, extensive posttranslational glycosylation results in CD44S having an apparent molecular mass on SDS\PAGE of 80-100 kDa. The expression of variant isoforms along with differential glycosylation alters the range of potential ligands the cell may respond to [25, 26] .
CD44 is expressed by many cell types, including leucocytes, erythrocytes, fibroblasts, endothelial and epithelial cells, and a variety of tumour cells [22] . Unusually for a cell surface receptor, CD44 seems to have broad ligand specificity, and has been proposed to bind the extracellular matrix molecules hyaluronan [27, 28] , fibronectin [29] , collagen [30] and fibrin [31, 32] . In addition, CD44 may bind to the proteoglycan serglycin found in lymphocyte and mast cell granules [33] , to the extracellular phosphoprotein osteopontin [34] , and to CD44 molecules on neighbouring cells [35] . The interaction of cell surface CD44 with hyaluronan is thought to be important in a variety of cell adhesion-related phenomena, but the functional relevance of the binding of CD44 to other putative ligands is poorly understood at present. Many diverse functions have been attributed to CD44, including involvement in cellular adhesion and migration, lymphocyte activation and proliferation, cytocidal activity of natural killer cells and tumour metastasis [36] . In other experimental systems, anti-CD44 antibodies can block the migration of murine pro-T cells into the thymus [36, 37] and prevent leucocyte extravasation at sites of inflammation [38] . Moreover, they can also stimulate leucocyte adhesion [39] and augment T cell activation [40] , suggesting that CD44 does indeed signal within the cell. This idea is supported further by the discovery that CD44 plays a role in cell spreading [41] , and cross-linking of CD44 on T cells is known to activate the tyrosine kinase p56 lck [42] . Src-family kinases have been shown to participate in CD44-mediated signalling resulting in cell spreading in CD45-deficient T cells [43] .
CD44 IS IMPORTANT IN INFLAMMATION
In recent years, several different observations have implicated CD44 in the regulation of the inflammatory response. Freshly isolated peripheral blood monocytes express CD44S strongly [44] , and the differentiation of monocytes into macrophages during in vitro culture is associated with increased expression of variant isoforms, while CD44S expression persists at high levels [45, 46] . Elevated local concentrations of CD44 ligands (such as hyaluronan and fibronectin) that follow tissue injury are likely to be important mediators of macrophage function as the inflammatory response progresses. Expression of the variant isoforms (CD44v6 and CD44v9) by monocyte-like THP-1 cells can be up-regulated following exposure to the inflammatory cytokines tumour necrosis factor α (TNFα) and interferon-γ [44] , and macrophage expression of some CD44 isoforms is increased at sites of chronic inflammation [46] . In vivo, systemic administration of anti-CD44 monoclonal antibodies reduced the severity of joint inflammation in mice with experimental arthritis [38, 47] .
While these studies provide circumstantial evidence for the involvement of CD44 in inflammation, more direct proof has come very recently from studies of lung inflammation in CD44-deficient knockout mice. Teder and colleagues [48] demonstrated that CD44-deficient mice exhibited unremitting and often fatal inflammation following bleomycin-induced lung injury compared with wild-type animals. The increased propensity to develop severe pneumonitis could be largely reversed by repopulating the bone marrow of the CD44-deficient mice with CD44j wild-type cells, demonstrating a critical role for CD44 expressed by macrophages or other haematopoietic cells in the resolution of lung inflammation.
CD44 LIGATION AUGMENTS THE PHAGOCYTOSIS OF APOPTOTIC NEUTROPHILS
To assess the role of macrophage CD44 in the phagocytosis of apoptotic neutrophils in vitro, anti-CD44 antibodies were used as convenient experimental surrogates for the natural ligand(s) of CD44. Adherent human monocyte-derived macrophages were incubated with anti-CD44 monoclonal antibodies for 20 min immediately prior to assessment of phagocytosis of apoptotic neutrophils using a well characterized assay [8, 49] . A control antibody (W6\32, against a non-polymorphic determinant on MHC class I) was chosen which, like the CD44 antibodies, bound strongly to human monocytederived macrophages. In this series of experiments, binding of anti-CD44 antibodies resulted in a dramatic increase in the macrophage-mediated phagocytosis of apoptotic neutrophils (Figure 4 ). Control antibody W6\32 had no significant effect, and neither did antibodies specific for integrin α5, β1 or β2 subunits [50] .
Conventionally, an in-well plate assay has been used to determine the proportion of phagocytic macrophages in experiments like these. However, there are several disadvantages to this approach : counting cells is somewhat subjective and prone to inter-observer variation ; there is Role of macrophage CD44 in disposal of inflammatory cell corpses
Figure 4 The anti-CD44 antibody 5A4 augments the macrophage-mediated phagocytosis of apoptotic neutrophils
Shown are representative micrographs from one experiment demonstrating the macrophage-mediated phagocytosis of apoptotic neutrophils following incubation with medium alone (left panel) or the anti-CD44 antibody 5A4 (right panel). After thorough washing and fixation, cells were stained for myeloperoxidase. Apoptotic neutrophils were 100 % myeloperoxidase-positive (dark reaction product), while macrophages were myeloperoxidase-negative. 5A4-treated wells show increases both in the proportion of macrophages that had phagocytosed apoptotic neutrophils and in the number of neutrophils per phagocytosing macrophage. The lower panels show results from a different experiment using a flow-cytometry-based phagocytosis assay to assess the effects of the anti-CD44 antibody 5A4. The percentages of macrophages that had ingested or not ingested fluorescent green-labelled aged neutrophils are shown.
often variability between samples due to the limited number of cells that can be counted ; and counting is time consuming. Also, selective detachment of phagocytic macrophages may occur during the washing process required following the assay, leading to an underestimate of phagocytosis. These problems may be circumvented by using a new flow-cytometry-based assay for measuring phagocytosis (H. Jersmann, S. Vivers, K. Ross, S. Brown and I. Dransfield, unpublished work). In this assay, neutrophils are labelled with a fluorescent green cytoplasmic dye and then aged in vitro in the usual way to induce apoptosis. When these apoptotic cells are phagocytosed, the green-labelled macrophages can be identified by flow cytometric analysis. This assay can be used to determine the number of macrophages that have phagocytosed apoptotic neutrophils within a certain period of time, without needing to wash the cells, so avoiding the potential problem of selective detachment. Some typical flow cytometry profiles are shown in Figure 4 .
Our analysis was extended to include other antibodies that recognize specific variant isoforms of CD44 expressed by human monocyte-derived macrophages. Interestingly, anti-CD44 antibodies that define the CD44v3 (antibody 3G5) or CD44v10 (2G1) isoforms, or a hyaluronan-binding-associated epitope (7F4), failed to augment phagocytosis, despite binding to macrophages. However, it is difficult to completely discount a role for specific isoforms of CD44 in the regulation of phagocytosis of apoptotic neutrophils based on the lack of an effect of single antibodies. Incubation of macrophages with monovalent Fabh antibody fragments was shown to have no effect on phagocytosis, whereas bivalent F(abh) # fragments augmented the phagocytosis of apoptotic neutrophils. This observation clearly rules out a role for macrophage Fcγ receptors. The lack of an effect of Fabh fragments of anti-CD44 antibodies indicates that bivalent antibody binding is required for the augmented phagocytosis of apoptotic neutrophils. The requirement for bivalent antibody is important, because it alludes to the possible underlying mechanism of action of CD44 ligation in these experiments. If simple masking of a CD44 epitope by an intact antibody was responsible for the observed effect, then monovalent Fabh fragments would be expected to act similarly. The requirement for bivalent binding implies that receptor cross-linking is a prerequisite, which then leads to initiation of intracellular signal transduction [51] . In physiological situations it is likely that CD44 on the macrophage surface would be cross-linked by large multivalent ligands in the extracellular matrix. However, we have excluded a role for the principal CD44 ligand hyaluronan, since the addition of soluble hyaluronan or adhesion of macrophages to hyaluronan-coated plastic did not significantly influence the phagocytic uptake of apoptotic neutrophils.
MECHANISMS OF CD44-AUGMENTED PHAGOCYTOSIS
We have considered a number of possibilities with regard to how the ligation of CD44 exerts its effect on the phagocytosis of apoptotic neutrophils. First, if CD44 were a constitutive negative regulator of apoptotic cell uptake, anti-CD44 antibodies could lead to the redistribution of CD44 into patches on the macrophage surface, thus allowing room for other receptors to interact with the apoptotic target. However, we could see no evidence of CD44 redistribution, as determined by fluorescence microscopy. Secondly, stimulation of CD44 may signal within the cell to promote phagocytosis. In support of this suggestion, the cytoplasmic tail of CD44 has been reported to interact with the cytoskeleton and with intracellular transduction molecules [52] . We believe that the CD44-directed recruitment of these effectors should provide the key to understanding the mechanism behind the augmented phagocytosis of apoptotic neutrophils. The small Rho-like GTPases such as Rac (analogous to ced-10), Rho and cdc42 act as molecular switches that control the organization of the actin cytoskeleton [15] , which is critical for particle engulfment during phagocytosis. In mouse mammary epithelial cells, ligation of CD44 triggers activation of Rac1 that results in rearrangements of the actin cytoskeleton [53] . Membrane recruitment of molecules such as Rac1 may be regulated by the guanine nucleotide exchange factor Tiam1, which has been suggested to associate with CD44 in breast tumour cells [54] . The cytoplasmic domain of CD44 may also associate directly with the Src-family kinases Lck and Fyn in lymphocytes [55] , and may rapidly induce tyrosine phosphorylation of p56 lck [42] . Src kinase activity may in turn result in the phosphorylation of Pyk2, a focal adhesion kinase (FAK) family member. A downstream target of both FAK and Pyk2 is paxillin, an important component of focal adhesions.
CELL-LINEAGE-SPECIFIC SURFACE ALTERATIONS DURING APOPTOSIS
Ligation of CD44 on human monocyte-derived macrophages by bivalent monoclonal antibodies rapidly and specifically augmented the phagocytosis of apoptotic neutrophils, but had no detectable effect on the phagocytosis of other particles or apoptotic lymphocytes. These results indicate that apoptosis may be associated with the expression of cell-specific markers that signal recognition and phagocytosis by macrophages [50] .
OTHER REGULATORS OF THE CLEARANCE OF APOPTOTIC CELLS
Some inflammatory mediators, such as prostaglandins, signal through activation of adenylate cyclase and elevation of intracellular cAMP levels. Prostaglandins can influence the immune response in a number of different ways, but prostaglandins E # and D # are capable of inhibiting the macrophage-mediated phagocytosis of apoptotic neutrophils in vitro [19] . Moreover, treatment of macrophages with a membrane-permeable analogue of cAMP also inhibited the uptake of apoptotic neutrophils [19] . Elevated levels of cAMP had no effect on FcγR-mediated phagocytosis, indicating specificity for the inhibition of apoptotic cell uptake. Elevation of cAMP concomitantly induced phenotypic alterations in the macrophage, including changes in the localization of actin and talin into discrete structures. Similar results have been observed when staining for vinculin, paxillin and tyrosine-phosphorylated proteins, suggesting that cAMP may uncouple adhesion receptors from cytoplasmic cytoskeletal elements, resulting in the observed morphological alterations.
Corticosteroids are used widely in the treatment of inflammatory diseases, and are known to inhibit inflammatory cell recruitment and dampen cellular responsiveness. They also have diverse effects on inflammatory cell apoptosis, promoting the apoptosis of thymocytes and eosinophils while inhibiting neutrophil apoptosis [56] . Treatment of human macrophages with glucocorti-coids markedly increased their capacity to phagocytose apoptotic neutrophils in vitro [57] . In contrast with CD44 ligation, the effect of glucocorticoids requires several hours of treatment and is inhibited by the protein synthesis blocker cycloheximide [14] . Also, phagocytic effects are not restricted to apoptotic target cells of the neutrophil lineage. Human monocytes treated with the glucocorticoid dexamethasone in vitro mature into a homogeneous population of macrophages with a typically smaller, more rounded appearance than untreated cells. This is associated with reduced expression of p130Cas [14] , an adaptor molecule that is predicted to disrupt Crk-DOCK180 (ced-2-ced-5) complexes, which are important for cell adhesion. This, combined with reduced phosphorylation and recruitment of paxillin and Pyk2 to sites of adhesion, may account for the changes in cell morphology and phagocytic capacity that accompany steroid hormone treatment [14] . Despite the rounded appearance of dexamethasone-treated cells, they remain highly membrane-active and can be observed rapidly contracting and expanding cellular processes. This may be attributable to increased levels of active GTP-bound Rac in the dexamethasone-treated macrophages [14] .
The adhesive state of a macrophage can modulate the phagocytic potential of the cell. The adhesion of macrophages to fibronectin, vitronectin or collagen VI increased the proportion of macrophages that ingested apoptotic neutrophils [58] . Macrophage adhesion to fibronectin may involve CD44, which can be ligated via heparin-binding sites. Heparin completely inhibited the augmentation by fibronectin of macrophage-mediated phagocytosis [58] . Despite this, treatment of macrophages with a proteolytic fragment of fibronectin which contained the major heparin-binding sites was unable to augment phagocytosis. This seems to suggest that, if fibronectin is a ligand for CD44 in this system, generation of a signal for augmented phagocytosis may require binding to more than one receptor. It is possible that the binding of a specific repertoire of macrophage adhesion receptors can influence the cell's potential for phagocytosis of apoptotic neutrophils. Macrophage production and deposition of matrix molecules in vitro may play a role in regulating the observed levels of phagocytosis of apoptotic cells.
Cytokines present at sites of inflammation have the potential to modulate cell behaviour, including the phagocytosis of a wide range of targets. A whole host of cytokines, including granulocyte-macrophage colonystimulating factor (GM-CSF), transforming growth factor-β1, interferon-γ, interleukin-1β and TNFα, have been shown to increase the uptake of apoptotic neutrophils by macrophages after a 4 h incubation. [18] . GM-CSF, interferon-γ, interleukin-1β and TNFα all play important roles in the initiation and amplification of an immune response. Moreover, they are present at sites of inflammation where monocytes mature into macrophages. Therefore these cytokines may assist in preparing macrophages to clear senescent neutrophils once they have undergone apoptosis.
CONCLUSION
The phagocytosis of apoptotic neutrophils, but not apoptotic lymphocytes, by human monocyte-derived macrophages is rapidly augmented following ligation of CD44 by bivalent antibodies in vitro. These observations, together with the lack of effect of anti-CD44 antibodies on the macrophage-mediated phagocytosis of other particles, imply that CD44 may regulate the differential clearance of apoptotic leucocytes during the evolution of inflammatory responses. We reproducibly observe a dramatic effect of CD44 ligation in a simple 30 min inwell phagocytosis assay, but this could feasibly translate into a massive extra capacity for clearance of apoptotic neutrophils in vivo, as the inflammatory process evolves over hours or days. The precise molecular pathway recruited following CD44 ligation remains to be defined. The rapidity of the effect of anti-CD44 antibodies and the requirement for bivalent binding suggests that ligation of macrophage CD44 by antibodies may trigger intracellular signalling pathways that lead to increased phagocytosis of apoptotic neutrophils. Rather than continuing to screen individual candidate receptors using inhibitory ligands or antibodies, we believe that a more promising approach will be to pursue the underlying regulatory mechanism by analysis of the intracellular molecular events and the functional responses that occur following macrophage CD44 ligation. 
